[1] BRUTON J D, LEMMENS R, SHI C L, et al. Ryanodine receptors of pancreatic beta-cells mediate a distinct context-dependent signal for insulin secretion. FASEB J, 2003,17(2):301-303.
[2] RAMALINGAM L, OH E, THURMOND D C. Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates. Cell Mol Life Sci, 2013,70(16):2815-2834.
[3] LIN H V, DOMENICO A. Reconstitution of insulin action in muscle, white adipose tissue, and brain of insulin receptor knock-out mice fails to rescue diabetes. J Biol Chem, 2011, 286(11):9797-9804.
[4] SALTIEL A R, KAHN C R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 2001, 414(6865):799-806.
[5] TATULIAN S A. Structural dynamics of insulin receptor and transmembrane signaling. Biochemistry, 2015, 54(36):5523-5532.
[6] WHITE M F. IRS2 integrates insulin/IGF1 signalling with metabolism, neurodegeneration and longevity. Diabetes Obes Metab, 2014, 16(Suppl 1):4-15.
[7] KANG S, TSAI L T, ROSEN E D. Nuclear mechanisms of insulin resistance . Trends Cell Biol, 2016, 26(5):341-351.
[8] RENSTR M F, BURN J, SVENSSON M, et al. Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes. Metabolism, 2007, 56(2):190-198.
[9] VOGT P K, HART J R, GYMNOPOULOS M, et al. Phosphatidylinositol 3-kinase:the oncoprotein. Curr Top Microbiol Immunol, 2010, 347(347):79-104.
MYERS M G J R, BACKER J M, SUN X J, et al. IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci USA, 1992, 89(21):10350-10354.
DUCLUZEAU P H, FLETCHER L M, WELSH G I, et al. Functional consequence of targeting protein kinase B/Akt to GLUT4 vesicles. J Cell Sci, 2002,115(Pt 14):2857-2866.
LEGUISAMO N M, LEHNEN A M, MACHADO U F, et al. GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Cardiovasc Diabetol,2012,11(5):100.
HUSSEY S E, MCGEE S L, GARNHAM A, et al. Exercise increases skeletal muscle GLUT4 gene expression in patients with type 2 diabetes. Diabetes Obes Metab, 2012,14(8):768-771.
HARDIE D G, ROSS F A, HAWLEY S A. AMPK:a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol, 2012, 13(4):251-262.
LEE-YOUNG R S, BONNER J S, MAYES W H, et al. AMP-activated protein kinase (AMPK)α2 plays a role in determining the cellular fate of glucose in insulin-resistant mouse skeletal muscle. Diabetologia, 2013, 56(3):608-617.
GUO Y, JIN M, TANG Y, et al. AMP-activated kinase α2 deficiency protects mice from denervation-induced skeletal muscle atrophy . Arch Biochem Biophys, 2016, 600:56-60.
HAWLEY S A, PAN D A, MUSTARD K J, et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab, 2005, 2(1):9-19.
FISHER J S. Potential role of the AMP-activated protein kinase in regulation of insulin action. J Cell Sci, 2006, 2(3):68-81.
LIONG S, LAPPAS M. Activation of AMPK improves inflammation and insulin resistance in adipose tissue and skeletal muscle from pregnant women. J Physiol Biochem, 2015, 71(4):703-717.
FILLMORE N, JACOBS D L, MILLS D B, et al. Chronic AMP-activated protein kinase activation and a high-fat diet have an additive effect on mitochondria in rat skeletal muscle. J Appl Physiol, 2010, 109(2):511-520.
HOTAMISLIGIL G S, SHARGILL N S, SPIEGELMAN B M. Adipose expression of tumor necrosis factor-alpha:direct role in obesity-linked insulin resistance. Science, 1993, 259(5091):87-91.
KHODABANDEHLOO H, GORGANI-FIRUZJAEE S, PANAHI S, et al. Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction . Transl Res, 2015, 167(1):228-256.
ODEGAARD J I, CHAWLA A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science, 2013, 339(6116):172-177.
CHEN L, CHEN R, WANG H, et al. Mechanisms linking inflammation to insulin resistance . Int J Endocrinol, 2015, 2015:508409.
AMERICAN DIABETES ASSOCIATION. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2011, 34(supplement-1):62-69.
NANDITHA A, MA R C, RAMACHANDRAN A, et al. Diabetes in Asia and the pacific:implications for the global epidemic . Diabetes Care, 2016, 39(3):472-485.
YANG W, LU J, WENG J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010,362(12):1090-1101.
ROSENSTOCK J, SHENOUDA S K, BERGENSTAL R M, et al. Baseline factors associated with glycemic control and weight loss when exenatide twice daily is added to optimized insulin glargine in patients with type 2 diabetes. Diabetes Care, 2012, 35(5):955-958.
WANG Z Z. The Study and Application of Exercise Prescription in the Early Stage of Diabetes(糖尿病前期人群运动处方研究与应用). Beijing:Beijing Sport University Press, 2010:41.
LARSEN C M, FAULENBACH M, VAAG A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med,2007, 356(15):1517-1526.
DONATH M Y, SHOELSON S E. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol, 2011,11(2):98-107.
LARSEN C M, FAULENBACH M, VAAG A, et al. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care, 2009, 32(9):1663-1668.
XIA X, YAN J, SHEN Y, et al. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS One, 2011, 6(2):e16556.
MA H, HU Y, ZOU Z, et al. Antihyperglycemia and antihyperlipidemia effect of protoberberine alkaloids from rhizoma coptidis in HepG2 cell and diabetic KK-Ay mice. Drug Dev Res, 2016,77(4):163-170.
SHUANG J, DU P, AN L, et al. Anti-diabetic effect of Coptis chinensis polysaccharide in high-fat diet with STZ-induced diabetic mice . Int J Biol Macromol, 2013, 55(3):118-122.
CUI L, LIU M, CHANG X, et al. The inhibiting effect of the Coptis chinensis polysaccharide on the type II diabetic mice . Biomed Pharmacother, 2016, 81:111-1192.
SUKSOMBOON N, POOLSUP N, PUNTHANITISARN S. Effect of Aloe vera, on glycaemic control in prediabetes and type 2 diabetes:a systematic review and Meta-analysis. J Clin Pharm Ther, 2016,41(2):180-188.
CHEN W X, YANG M, YU D W,et al. Hypoglycemic effect and mechanism of the ginseng glycopeptide in diabetic rats with QI and Yin Deficiency . Chin Pharm J(中国药学杂志), 2014, 49(21):1903-1907.
YU X C, YANG W, WU B L, et al. Predication of anti-oiabetes effects of Corydalis yanhusuo alkaloids with pharmacological network technology and experimental validation in ICR mice . Chin Pharm J(中国药学杂志), 2014, 49(11):913-918.
Ch. P(2015) Vol Ⅰ(中国药典2015年版.一部). 2015:446, 925, 1076, 1124, 1139, 1283, 1430-1433, 1627, 1719.
YANG Z, WANG L, FENG Z, et al. Evaluating the antidiabetic effects of Chinese herbal medicine:Xiao-Ke-An in 3T3-L1 cells and KKAy mice using both conventional and holistic omics approaches. BMC Complement Altern Med, 2015, 15(1):1-12.
LIN Y J, HO T J, YEH Y C, et al. Chinese herbal medicine treatment improves the overall survival rate of individuals with hypertension among type 2 diabetes patients and modulates in vitro smooth muscle cell contractility. PLoS One, 2015, 10(12):e0145109.
LEE S Y, LAI F Y, SHI L S, et al. Rhodiolacrenulata extract suppresses hepatic gluconeogenesis via activation of the AMPK pathway. Phytomedicine, 2015,22(4):477-486.
FARSI E, AHMAD M, HOR S Y, et al. Standardized extract of Ficus deltoidea stimulates insulin secretion and blocks hepatic glucoseproduction by regulating the expression of glucose-metabolic genes in streptozitocin-induced diabetic rats. BMC Complement Altern Med, 2014,14(1):1-13.
PANG B, ZHOU Q, ZHAO T Y, et al. Innovative thoughts on treating diabetes from the perspective of traditional Chinese medicine. Evid Based Complement Alternat Med, 2015,2015:905432.
WEN-CHIN Y, SRINIVAS N, PER BENDIX J, et al. Complementary and alternative medicine for diabetes. Evid Based Complement Alternat Med, 2013, 2013(6):568-579.
LI N, LIU Q, LI X J, et al. TCM formula Xiaoyaosan Decoction improves depressive-like behaviors in rats with type 2 diabetes. Evid Based Complement Alternat Med, 2015,2015:415243.
CAI H, LIAN L, WANG Y, et al. Protective effects of Salvia miltiorrhiza injection against learning and memory impairments in streptozotocin-induced diabetic rats. Exp Ther Med, 2014, 8(4):1127-1130.
ZHANG H M, LIANG F X, CHEN R. Ancient records and modern research on the mechanisms of Chinese herbal medicines in the treatment of diabetes mellitus. Evid Based Complement Alternat Med, 2015, 2015:1-14.
ALINEJAD-MOFRAD S, FOADODDINI M, SAADATJOO S A, et al. Improvement of glucose and lipid profile status with Aloe vera in pre-diabetic subjects:a randomized controlled-trial. J Diabetes Metab Disord, 2015,14(1):1-7.
LI Z, GENG Y N, JIANG J D, et al. Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement Alternat Med, 2014, 2014(1):71-80.
VAREDA P M. Myrcia bella leaf extract presents hypoglycemic activity via PI3k/Akt insulin signaling pathway. Evid Based Complement Alternat Med, 2014, 2014(1):133.
YANG J, MAO Q X, XU H X, et al. Tea consumption and risk of type 2 diabetes mellitus:a systematic review and Meta-analysis update. BMJ Open, 2014, 4(7):e005632.
HEEYOUNG C, PATRICK G. Can tea extracts exert a protective effect against diabetes by reducing oxidative stress and decreasing glucotoxicity in pancreatic β-cells . Diabetes Metab J, 2015,39(1):27-30.
NIE X Q, CHEN H H, ZHANG J Y, et al. Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways. Acta Pharmacol Sin(中国药理学报), 2016, 37(4):483-496.